Metabolic-only response assessment for omission of residual node radiation therapy (RNRT) for patients with classical Hodgkin lymphoma (cHL) and impact on event free (EFS) and overall survival (OS): A report from the Pediatric Hodgkin Consortium’s phase 2 study cHOD17 (NCT03755804).
Jamie E. Flerlage(St. Jude Children's Research Hospital), Angela M. Feraco(Dana-Farber Cancer Institute), John T. Lucas(Wake Forest University), Torunn I. Yock(Massachusetts General Hospital), Eric Larsen(University of Massachusetts Chan Medical School), Yiwang Zhou(St. Jude Children's Research Hospital), Christine Bolen(Novant Health), Stephan D. Voss(Brigham and Women's Hospital), Lianna J. Marks(Stanford Medicine), Shannon M. MacDonald(Massachusetts General Hospital), Matthew J. Ehrhardt(St. Jude Children's Research Hospital), Ying Zheng(Chinese People's Liberation Army), Pedro A. de Alarcón(Illinois College), Alison M. Friedmann(Harvard University), Howard J. Weinstein(Harvard University Press), Michael P. Link(Stanford University), Jessi Rogers-Blake(St. Jude Children's Research Hospital), Susan M. Hiniker(Stanford University), Lindsay Wilemon(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|920